Citation

Pomerantz JM. Drug Benefit Trends 2002; 14(4): 22-23.

Copyright

(Copyright © 2002)

DOI

unavailable

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

amfebutamone; antidepressant agent; anxiety neurosis; clinical trial; comparative study; convalescence; depression; disability; drug cost; drug efficacy; drug marketing; drug withdrawal; dysthymia; ejaculation; fluoxetine; Hamilton scale; human; job performance; libido; meta analysis; mirtazapine; monoamine oxidase inhibitor; nefazodone; neuroleptic agent; obsession; orgasm; panic; paroxetine; patient compliance; penis erection; placebo; prescription; relapse; remission; review; serotonin uptake inhibitor; sertraline; sexual dysfunction; side effect; suicide; symptom; tricyclic antidepressant agent; venlafaxine; weight gain